How herpes simplex virus affects the body's DNA damage response and protein changes.

Manipulation of the DNA damage response and the proteome on viral genomes during Herpes Simplex Virus (HSV) infection

['FUNDING_R01'] · CHILDREN'S HOSP OF PHILADELPHIA · NIH-11026740

This study is looking at how the herpes virus affects our body's natural defenses against DNA damage while it’s infecting us, which could help us find new ways to treat the virus.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorCHILDREN'S HOSP OF PHILADELPHIA (nih funded)
Locations1 site (PHILADELPHIA, UNITED STATES)
Trial IDNIH-11026740 on ClinicalTrials.gov

What this research studies

This research investigates how the herpes simplex virus (HSV) interacts with the body's DNA damage response mechanisms during infection. It focuses on understanding how the virus manipulates these cellular processes to enhance its replication. By utilizing advanced proteomics techniques, the study aims to identify the specific signaling networks and protein changes that occur when the virus infects host cells. This could lead to new insights into viral behavior and potential therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with herpes simplex virus infections, particularly those experiencing recurrent outbreaks.

Not a fit: Patients with other viral infections or those who do not have herpes simplex virus may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of new antiviral therapies that more effectively combat herpes simplex virus infections.

How similar studies have performed: Previous research has shown success in understanding viral manipulation of host cellular processes, suggesting that this approach may yield valuable insights.

Where this research is happening

PHILADELPHIA, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.